TY  - JOUR
A1  - Wicha, Sebastian G.
A1  - Huisinga, Wilhelm
A1  - Kloft, Charlotte
T1  - Translational pharmacometric evaluation of typical antibiotic broad-spectrum combination therapies against staphylococcus aureus exploiting in vitro information
T2  - CPT: pharmacometrics & systems pharmacology
N2  - Broad-spectrum antibiotic combination therapy is frequently applied due to increasing resistance development of infective pathogens. The objective of the present study was to evaluate two common empiric broad-spectrum combination therapies consisting of either linezolid (LZD) or vancomycin (VAN) combined with meropenem (MER) against Staphylococcus aureus (S. aureus) as the most frequent causative pathogen of severe infections. A semimechanistic pharmacokinetic-pharmacodynamic (PK-PD) model mimicking a simplified bacterial life-cycle of S. aureus was developed upon time-kill curve data to describe the effects of LZD, VAN, and MER alone and in dual combinations. The PK-PD model was successfully (i) evaluated with external data from two clinical S. aureus isolates and further drug combinations and (ii) challenged to predict common clinical PK-PD indices and breakpoints. Finally, clinical trial simulations were performed that revealed that the combination of VAN-MER might be favorable over LZD-MER due to an unfavorable antagonistic interaction between LZD and MER.
Y1  - 2017
UR  - https://publishup.uni-potsdam.de/frontdoor/index/index/docId/54749
SN  - 2163-8306
VL  - 6
SP  - 512
EP  - 522
PB  - Wiley
CY  - Hoboken
ER  -